name nAnno nOverlap fc zscore pvalue adjp or CIl CIu
path:hsa04724 Glutamatergic synapse 114 6 7.6 5.94 0.00012 0.0067 9 3.06 22
path:hsa04070 Phosphatidylinositol signaling system 97 5 7.45 5.34 0.00051 0.014 8.62 2.6 22.5
path:hsa00562 Inositol phosphate metabolism 71 4 8.14 5.05 0.0014 0.014 9.27 2.35 26.6
path:hsa04971 Gastric acid secretion 75 4 7.7 4.87 0.0017 0.014 8.75 2.22 25.1
path:hsa04022 cGMP-PKG signaling pathway 163 6 5.32 4.66 0.00083 0.014 6.15 2.1 14.9
path:hsa04611 Platelet activation 123 5 5.87 4.55 0.0015 0.014 6.69 2.03 17.4
path:hsa04020 Calcium signaling pathway 181 6 4.79 4.31 0.0014 0.014 5.5 1.88 13.3
path:hsa04080 Neuroactive ligand-receptor interaction 277 7 3.65 3.76 0.0027 0.019 4.2 1.57 9.62
path:hsa04915 Estrogen signaling pathway 98 4 5.9 4.08 0.0045 0.028 6.58 1.68 18.7
path:hsa04922 Glucagon signaling pathway 102 4 5.66 3.96 0.0052 0.029 6.31 1.61 17.9
path:hsa04726 Serotonergic synapse 112 4 5.16 3.71 0.0072 0.037 5.72 1.46 16.2
path:hsa04730 Long-term depression 60 3 7.22 4.04 0.0081 0.038 8 1.54 26.2
path:hsa04924 Renin secretion 65 3 6.67 3.83 0.01 0.042 7.35 1.42 24
path:hsa04720 Long-term potentiation 67 3 6.47 3.76 0.011 0.042 7.12 1.38 23.2
path:hsa05031 Amphetamine addiction 68 3 6.37 3.72 0.011 0.042 7 1.36 22.8
path:hsa04728 Dopaminergic synapse 130 4 4.44 3.31 0.012 0.042 4.89 1.25 13.8
path:hsa04918 Thyroid hormone synthesis 74 3 5.86 3.51 0.014 0.045 6.41 1.24 20.8
path:hsa04015 Rap1 signaling pathway 210 5 3.44 3 0.014 0.045 3.8 1.16 9.76
path:hsa04925 Aldosterone synthesis and secretion 82 3 5.28 3.26 0.019 0.05 5.75 1.12 18.6
path:hsa04911 Insulin secretion 85 3 5.1 3.17 0.021 0.05 5.54 1.08 17.9
path:hsa04072 Phospholipase D signaling pathway 145 4 3.98 3.03 0.017 0.05 4.36 1.12 12.3
path:hsa04723 Retrograde endocannabinoid signaling 148 4 3.9 2.98 0.019 0.05 4.27 1.1 12
path:hsa04921 Oxytocin signaling pathway 152 4 3.8 2.92 0.02 0.05 4.15 1.07 11.7
